Prana to Be Featured in Alzheimer's Disease Conference Call
           

MELBOURNE, AUSTRALIA--(Marketwire - March 14, 2008) -  Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and
development of treatments for neurodegenerative disorders, today announced
that the Company will be featured on a conference call on Friday, March 14
at 1 p.m. EDT, coordinated by Rodman & Renshaw, to discuss innovative
approaches in Alzheimer's disease therapy.

           

http://www.marketwire.com/mw/release.do?id=832454&sourceType=3